Prostate News Archive
13-Aug-2006
Prostate cancer treatment 'too costly' (The Australian)
MEN with prostate cancer are disadvantaged as they try to access an expensive chemotherapy drug, which is listed on the Pharmaceutical Benefits Scheme only for women, a urologist says. RNA-Based Drug Kills Prostate-Cancer Cells (RedNova)
Researchers at Duke University recently discovered that using a two-module ribonucleic acid system safely reduces prostate-tumor size two-fold. Analysis: Less is more for prostate CA? (UPI)
ANN ARBOR, Mich., Aug. 11 (UPI) -- More than half of men with low-risk prostate cancer would do better with a "watch and wait" approach to their illness, instead of receiving aggressive treatment that produces no survival benefit, says a new study. Drug kills prostate tumor cells (PhysOrg)
U.S. scientists have developed an experimental RNA-based drug -- the first of its kind -- that kills prostate cancer cells, without harming normal cells. Prostate surgery's new super laser now in SA (Independent Online)
A revolution in laser surgery set to change the future of prostate surgery has arrived in South Africa. Protox advances phase I prostate cancer study forward (Pharmaceutical Business Review)
Protox Therapeutics has announced today that the first two cohorts of patients in its phase I clinical trial for prostate cancer using PRX302 have been treated safely and that dose escalation to the third cohort will commence shortly. Prostate Cancer Patients Sought for Database as Part of Joint Effort (Newswise)
Cedars-Sinai Medical Center's Louis Warschaw Prostate Cancer Center at the Samuel Oschin Comprehensive Cancer Institute in Los Angeles is seeking participants for its Prostate Patient Profiles Project, in conjunction with Centinela Freeman Regional Medical Center, Memorial Campus in Inglewood. First-Ever RNA Drug Targets Prostate Cancer (MedicineNet.com)
Title: First-Ever RNA Drug Targets Prostate Cancer Category: Health News Created: 8/10/2006 1:57:00 AM Last Editorial Review: 8/10/2006 1:56:49 AM First-Ever RNA Drug Targets Prostate Cancer (HealthDay via Yahoo! News)
WEDNESDAY, Aug. 9 (HealthDay News) -- An experimental gene-based drug is able to "trick" its way into prostate cancer cells and kill them, U.S. researchers report. Experimental RNA-based Drug Kills Prostate Cancer Cells Effectively And Safely (Medical News Today)
Acting as a genetic Trojan horse, an experimental RNA-based drug -- the first of its kind -- tricks its way into prostate cancer cells and then springs into action to destroy them, while leaving normal cells unarmed. [click link for full article]
Back to Prostate News Archive
